methotrexat ebewe
ebewe pharma ges.m.b.h. nfg. kg - metotreksatas - injekcinis ar infuzinis tirpalas - 2,5 mg; 100 mg/ml; 10 mg/ml - methotrexate
methotrexate accord
accord healthcare b.v. - metotreksatas - koncentratas infuziniam tirpalui - 25 mg/ml; 100 mg/ml - methotrexate
ibuprofen nutra essential
nutra essential otc s.l. - ibuprofenas - geriamoji suspensija paketėlyje - 400 mg; 200 mg; 100 mg - ibuprofen
ostemax
pharmaceutical works polpharma s.a. - alendrono rūgštis - tabletės - 70 mg - alendronic acid
methotrexate orion
orion corporation - metotreksatas - tabletės - 2,5 mg; 10 mg - methotrexate
tridepos
sia meda pharma - alendrono rūgštis+kalcis/kolekalciferolis - tabletės - 70 mg + 500 mg/800 tv - alendronic acid, calcium and colecalciferol, sequential
alendronic acid accord
accord healthcare b.v. - alendrono rūgštis - tabletės - 70 mg - alendronic acid
efexor xr
upjohn eesv - venlafaksinas - pailginto atpalaidavimo kietosios kapsulės - 37,5 mg; 150 mg; 75 mg - venlafaxine
imfinzi
astrazeneca ab - durvalumab - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
acido alendronico semanal kern pharma
lex ano, uab - alendrono rūgštis - tabletės - 70 mg - alendronic acid